Castor Oil
CAS 8001-79-4
Castor Oil (CAS 8001-79-4) is a pharmaceutical compound with 0 bioactivity targets and 20 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| RICINUS COMMUNIS (CASTOR) SEED OIL | 2129 | SU | MTHSPL |
| CASTOR OIL | 2129 | SU | MTHSPL |
| Castor Oil | 2129 | SU | MTHSPL |
| castor oil | 2129 | SU | MTHSPL |
| castor oil | 2129 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Castor Oil used for in pharmaceutical contexts?
Castor Oil (CAS 8001-79-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Castor Oil?
Castor Oil has 20 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Chronic inflammatory demyelinating polyradiculoneuropathy, Dementia Alzheimer's type, Diabetic neuropathy, Drug ineffective, Fall. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Castor Oil also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Castor Oil (Ricinus Communis Seed Oil) with EU status "permitted".
What clinical phase is Castor Oil in?
No phase 1-4 clinical development badge is rendered for Castor Oil because the matched compound identifier rows do not contain a max-phase value.